Article
Tnni3k modifies disease progression in murine models of cardiomyopathy.
PLoS genetics - 1 Sept 2009
Wheeler Ferrin C, Tang Hao, Marks Odessa A, Hadnott Tracy N, Chu Pei-Lun, Mao Lan, Rockman Howard A, Marchuk Douglas A
Abstract excerpt
The Calsequestrin (Csq) transgenic mouse model of cardiomyopathy exhibits wide variation in phenotypic progression dependent on genetic background. Seven heart failure modifier (Hrtfm) loci modify disease progression and outcome. Here we report Tnni3k (cardiac Troponin I-interacting kinase) as the gene underlying Hrtfm2. Strains with the more susceptible phenotype exhibit high transcript levels while less...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
